Aether Industries jumps on executing supply and sales agreement with Otsuka Chemical Company

Aether Industries jumps on executing supply and sales agreement with Otsuka Chemical Company

by 5paisa Research Team Last Updated: Mar 06, 2023 - 12:16 pm 674 Views

Today, the stock opened at Rs 890 and touched a high and low of Rs. 905.60 and Rs 871.85 respectively. 

Execution of sales agreement

Aether Industries executed a long-term Supply and Sales Agreement on March 3, 2023, with Otsuka Chemical Company, Japan, along with Chori Company, Japan (being the Agent of Otsuka Chemical Company).

The Agreement is executed for the supply and sale of specific existing speciality intermediates of Aether Industries to Otsuka Chemical Co., Japan. The Agreement is for supply and sales by Aether Industries to Otsuka Chemical Co., Japan for a period of 10 years, which will be enhanced for a further period (after 10 years) with mutual consent of both parties to the Agreement.

At maturity, within 3 years, a combined quantity of 300 MT (of the products) per year will be supplied by Aether Industries to Otsuka Chemical Co., Japan, and hence the revenue potential for the said agreement would be Rs 510 million per year in the Large-Scale Manufacturing business model. Aether Industries will be the exclusive supplier to Otsuka Chemical Co., Japan for the products for which the Agreement is executed. 

Stock price movement

The BSE group 'B' stock of face value of Rs 10 has touched a 52-week high and low of Rs 1050 and Rs 699.85, respectively. Last one week high and low of the scrip stood at Rs 905.60 and Rs 852.00 respectively. The current market cap of the company is Rs 11,041.61 crore.

Company Profile

Aether Industries is a speciality chemicals manufacturer in India focused on producing advanced intermediates and specialty chemicals involving complex and differentiated chemistry and technology core competencies. 

Share Market Today

How do you rate this article?


Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.


Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial. Also, The
Open Free Demat Account
Resend OTP
Please Enter OTP
Account belongs to

By proceeding, you agree to the T&C.

Latest News
Unihealth Consultancy IPO lists at 2.27% premium, tapers later

Tepid listing for Unihealth Consultancy IPO on the NSE-SME

  • Sep 21, 2023
EMS IPO lists at 33.67% premium, tapers post listing

EMS IPO had a strong listing on 21st September 2023, listing at a smart premium of 33.67%, but tapering towards the close to list below the listing price.

  • Sep 21, 2023
Madhusudan Masala IPO Closing Subscription Details

The IPO of Madhusudan Masala Ltd closed on Thursday, 21st September 2023. The IPO had opened for subscription on 18th September 2023. Let us look at the final subscription status of Madhusudan Masala Ltd at the close of subscription on 21st September 2023.

  • Sep 21, 2023